Early response with dasatinib or imatinib in chronic myeloid leukemia: 3-year follow-up from a randomized phase 3 trial (DASISION)

This analysis explores the impact of early cytogenetic and molecular responses on the outcomes of patients with chronic myeloid leukemia in chronic phase (CML-CP) in the phase 3 DASatinib versus Imatinib Study In treatment-Naive CML patients trial with a minimum follow-up of 3 years. Patients with n...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Jabbour, Elias, Kantarjian, Hagop M., Saglio, Giuseppe, Steegmann, Juan Luis, Shah, Neil P., Boqué, Concepción, Chuah, Charles, Pavlovsky, Carolina, Mayer, Jiří, Cortes, Jorge, Baccarani, Michele, Kim, Dong-Wook, Bradley-Garelik, M. Brigid, Mohamed, Hesham, Wildgust, Mark, Hochhaus, Andreas
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2014
Assuntos:
Clinical Trials and Observations
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4190618/
https://ncbi.nlm.nih.gov/pubmed/24311723
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2013-06-511592
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados